Inflammation and vascular injury: basic discovery to drug development

Area of Science:

• Cardiovascular Biology
• Immunology
• Vascular Inflammation

Background:

• Mechanical vascular injury triggers an inflammatory response, challenging the view of restenosis as solely a smooth muscle cell proliferation issue.
• Early research established that leukocyte accumulation contributes to neointimal formation after vascular injury.
• The role of inflammation in vascular repair and disease pathogenesis was not fully understood.

Purpose of the Study:

• To elucidate the central role of inflammation in vascular injury and repair.
• To identify key molecular mechanisms, particularly leukocyte recruitment pathways.
• To explore therapeutic targets for inflammatory vascular conditions.

Main Methods:

• Investigated the effects of antibody targeting of Mac-1 on leukocyte accumulation and neointimal formation in response to vascular injury.
• Utilized genetically modified mice lacking Mac-1 to assess its role in neointimal thickening after carotid artery injury.
• Mapped the binding site of platelet glycoprotein (GP) Ibα to Mac-1 and studied the functional consequences of this interaction.

Main Results:

• Antibody targeting of Mac-1 and genetic absence of Mac-1 significantly reduced leukocyte accumulation and neointimal formation.
• Platelet GP Ibα was identified as the counter-receptor for Mac-1, crucial for leukocyte recruitment to injured vessels.
• Mac-1-GPIbα interaction is vital for thrombosis, vasculitis, glomerulonephritis, and multiple sclerosis, supporting a platelet-dependent inflammation hypothesis.
• Mac-1 activation initiates a gene program involving NFκB and Foxp1, promoting inflammation and affecting monocyte differentiation.

Conclusions:

• Inflammation, mediated by leukocyte recruitment via the Mac-1 integrin, plays a central role in vascular injury and repair.
• The interaction between Mac-1 and platelet GP Ibα is a critical pathway in vascular inflammation and various other inflammatory diseases.
• Targeting Mac-1 function or its interaction with GP Ibα represents a promising therapeutic strategy for inflammatory and thrombotic disorders.